LivingGLP1
Study S001546

Region-specific Adipose Tissues and Liver Changes Associated With Semaglutide Treatment in Chronic Kidney Disease Patients

Registration

Registration
NCT07187830
Acronym
ADIPOLIVE
Study type
OBSERVATIONAL
Status
RECRUITING
Enrollment
52
Start
2026-02-23
Primary completion
2027-12-15
Lead sponsor
University of Alberta
Conditions
Chronic Kidney Disease in Type 2 Diabetes; Obesity & Overweight
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Correlation between kidney disease progression and cardiometabolic changes [From enrollment to the end of follow-up at 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.